A Multi-Center, Randomized, Blinded, Parallel-Group Study of AVONEX Compared With AVONEX in Combination With Oral Methotrexate, Intravenous Methylprednisolone, or Both in Subjects With Relapsing Remitting MS Who Have Breakthrough Disease on AVONEX Monotherapy.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary) ; Methotrexate; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ACT
- Sponsors Biogen
- 10 Feb 2009 Results published in Neurology.
- 05 May 2007 Initial results were reported at AAN 2007.
- 05 May 2007 Status changed from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History